FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to therapy and anesthesiology-resuscitation, and can be used to predict the occurrence of acute kidney injury (AKI) in pneumonia associated with COVID-19, by the level of s-CysC. Determine the concentration of s-CysC in samples of venous blood of patients by immunoturbidimetric method. If the concentration of s-CysC in patients from more than 1.67 up to 1.69 mg / l inclusive, then the occurrence of AKI is predicted after 2 days. If the concentration of s-CysC in patients exceeds 1.69 mg/l, then AKI is predicted 1 day after taking a venous blood sample for analysis.
EFFECT: method makes it possible to predict the occurrence of AKI in pneumonia associated with COVID-19 by determining the level of CysC in the blood, a reliable diagnostic and prognostic biomarker of AKI in pneumonia associated with COVID-19.
1 cl, 1 dwg, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING UNFAVORABLE OUTCOME OF SEVERE PNEUMONIA ASSOCIATED WITH COVID-19 BY u-CysC LEVEL | 2022 |
|
RU2779579C2 |
| METHOD FOR ASSESSING UNFAVORABLE OUTCOME OF SEVERE PNEUMONIA ASSOCIATED WITH COVID-19 BY s-CysC LEVEL | 2022 |
|
RU2779581C2 |
| METHOD FOR PREDICTION OF ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE CORONARY SYNDROME USING A RISK SCALE | 2019 |
|
RU2724017C1 |
| METHOD OF PREDICTING THE RISK OF DEVELOPING CHRONIC HEART FAILURE IN PATIENTS WHO HAVE HAD A NEW CORONAVIRUS INFECTION COVID-19 | 2023 |
|
RU2805601C1 |
| METHOD FOR TREATING PATIENTS WITH HIV-ASSOCIATED LYMPHOPROLIFERATIVE DISEASES WITH MODERATE AND SEVERE COVID-19 | 2022 |
|
RU2793414C1 |
| METHOD FOR PREDICTING PROBABILITY OF DEATH IN PATIENTS WITH SEVERE COVID-19-ASSOCIATED PNEUMONIA | 2023 |
|
RU2826883C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPMENT OF ACUTE KIDNEY INJURY IN PATIENTS AFTER PARATHYROIDECTOMY FOR PRIMARY HYPERPARATHYROIDISM | 2020 |
|
RU2781110C2 |
| METHOD FOR PREDICTION OF DEVELOPMENT OF ACUTE KIDNEY DAMAGE DURING MYOCARDIAL INFARCTION IN MEN UNDER 60 YEARS | 2022 |
|
RU2784943C1 |
| METHOD FOR PREDICTING THE EFFICIENCY OF ANTI-INFLAMMATORY THERAPY WITH GLUCOCORTICOSTEROID HORMONES IN PATIENTS WITH MODERATE COVID-19 | 2022 |
|
RU2780933C1 |
| METHOD FOR PREDICTING OUTCOME OF ACUTE PERIOD OF ISCHEMIC STROKE ASSOCIATED WITH COVID-19 | 2021 |
|
RU2763834C1 |
